Clopidogrel Response Evaluation and AnTi-Platelet InterVEntion in High Thrombotic Risk PCI Patients

NCT01779401 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

1078

Enrollment

OTHER

Sponsor class

Conditions

Coronary Heart Disease

Interventions

DRUG: Clopidogrel 75mg
DRUG: Clopidogrel 150mg
DRUG: Aspirin 100mg
DRUG: Cilostazol 100mg

Sponsor

Chinese Academy of Medical Sciences, Fuwai Hospital

Collaborators

[object Object]
[object Object]
[object Object]